Previous issues
Editorials
Transcatheter mitral valve replacement: there is no one-size-fits-all solution
REC Interv Cardiol. 2020;2:161-162
Drug-coated balloon catheters. Discussing mortality from the coronary perspective
REC Interv Cardiol. 2020;2:163-165
Scientific debates among professionals in social media: a fantastic, but not risk-free scenario
REC Interv Cardiol. 2020;2:166-167
Original Articles
Bioresorbable vascular scaffolds in the routine clinical practice: long-term results
REC Interv Cardiol. 2020;2:168-174
Pharmacoinvasive strategy as reperfusion treatment in non-capable primary percutaneous coronary intervention areas
REC Interv Cardiol. 2020;2:175-182
Fifteen years of percutaneous coronary interventions for chronic total coronary occlusions. Experience, results, and clinical outcomes
REC Interv Cardiol. 2020;2:183-190
Single low-dose of apixaban in patients with atrial fibrillation after transcatheter aortic valve implantation
REC Interv Cardiol. 2020;2:191-198
Review Article
Specific indications for TAVI
REC Interv Cardiol. 2020;2:206-214
Debate
Debate: Mechanical circulatory support in relation to coronary intervention. The interventional cardiologist perspective
REC Interv Cardiol. 2020;2:215-216
Debate: Mechanical circulatory support in relation to coronary intervention. Cardiologist’s perspective from the cardiac intensive care unit
REC Interv Cardiol. 2020;2:217-218
Clinical Case
Bail-out alcohol septal ablation in the management of obstructive hypertrophic cardiomyopathy and refractory electrical storm
REC Interv Cardiol. 2020;2:219-220
Images in cardiology
Pulmonary arteriovenous fistula as a possible cause for myocardial infarction
REC Interv Cardiol. 2020;2:224-225
Percutaneous reconstruction of pulmonary trunk to solve stent embolization
REC Interv Cardiol. 2020;2:226-227
Scientific letters
Use of radial access to create an arterio-arterial loop to facilitate the percutaneous closure of paravalvular aortic leak. Is it feasible?
REC Interv Cardiol. 2020;2:228-229
Transcatheter aortic valve implantation during the current COVID-19 pandemic. Recommendations from the ACI-SEC
REC Interv Cardiol. 2020;2:230-231
Editorials
Transcatheter aortic valve replacement for noncalcified aortic regurgitation. Where are we now?
aServicio de Cardiología, Hospital Clínico Universitario, Valladolid, Spain
bCentro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain
Original articles
Editorials
Vascular closure devices: the jury is still out
aUnidad de Hemodinámica, Servicio de Cardiología, Hospital General Universitario Dr. Balmis, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain
bDepartamento de Medicina Clínica, Universidad Miguel Hernández, Alicante, Spain
Original articles
Debate
Debate: Asymptomatic severe aortic stenosis: when should we intervene?
The clinician’s perspective
Servicio de Cardiología, Hospital Ramón y Cajal, Madrid, Spain
The interventional cardiologist’s perspective
Unidad de Cardiología Intervencionista, Hospital Álvaro Cunqueiro, Complejo Hospitalario Universitario de Vigo, Vigo, Pontevedra, Spain